{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:27:40Z","timestamp":1793924860179,"version":"4.8.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["21A2013D"],"award-info":[{"award-number":["21A2013D"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["23A2020D"],"award-info":[{"award-number":["23A2020D"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["19K059"],"award-info":[{"award-number":["19K059"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine","doi-asserted-by":"publisher","award":["24A1011"],"award-info":[{"award-number":["24A1011"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020237","name":"Japan Health Research Promotion Bureau","doi-asserted-by":"publisher","award":["2020-B-09"],"award-info":[{"award-number":["2020-B-09"]}],"id":[{"id":"10.13039\/100020237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020237","name":"Japan Health Research Promotion Bureau","doi-asserted-by":"publisher","award":["2024-B-01"],"award-info":[{"award-number":["2024-B-01"]}],"id":[{"id":"10.13039\/100020237","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vaccine.2026.129242","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:58:37Z","timestamp":1792087117000},"page":"129242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Protection of Omicron XBB.1.5 vaccine, previous infection, and their induced neutralizing antibodies against symptomatic SARS-CoV-2 infection during Omicron KP.3 wave"],"prefix":"10.1016","volume":"94","author":[{"given":"Shohei","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Mizoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumi","family":"Horii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Inamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Akahori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko S.","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2026.129242_bb0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the Omicron variant and severe disease: a systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2026.129242_bb0010","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMc2402779","article-title":"Durability of XBB.1.5 vaccines against Omicron subvariants","volume":"390","author":"Lin","year":"2024","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129242_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106293","article-title":"Protection of vaccine boosters and prior infection against mild\/asymptomatic and moderate COVID-19 infection in the UK SIREN healthcare worker cohort: October 2023 to March 2024","volume":"89","author":"Kirwan","year":"2024","journal-title":"J Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129242_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae519","article-title":"Protection of Omicron bivalent vaccine, previous infection, and their induced neutralizing antibodies against symptomatic infection with Omicron XBB.1.16 and EG.5.1","volume":"11","author":"Yamamoto","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129242_bb0025","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1016\/S1473-3099(24)00415-8","article-title":"Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants","volume":"24","author":"Kaku","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129242_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127472","article-title":"Neutralizing antibody evasion of SARS-CoV-2 JN.1 derivatives KP.3, KP.3.1.1, LB.1, and XEC","volume":"62","author":"Sano","year":"2025","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129242_bb0035","article-title":"Comparative analysis of host cell entry efficiency and neutralization sensitivity of emerging SARS-CoV-2 lineages KP.2, KP.2.3, KP.3, and LB.1","volume":"12","author":"Chen","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"814","key":"10.1016\/j.vaccine.2026.129242_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adu8067","article-title":"The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins","volume":"17","author":"Kumar","year":"2025","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129242_bb0045","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1080\/14760584.2025.2576243","article-title":"Effectiveness of the autumnal COVID-19 vaccine dose during the winter and summer waves of the 2023\/24 season in Spain","volume":"24","author":"Rojas-Benedicto","year":"2025","journal-title":"Expert Rev Vaccines"},{"issue":"8047","key":"10.1016\/j.vaccine.2026.129242_bb0050","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41586-024-08315-x","article-title":"Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1","volume":"637","author":"Jian","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.129242_bb0055","first-page":"1","article-title":"Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research center in Tokyo after the emergence of variants","author":"Mizoue","year":"2023","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129242_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.35772\/ghm.2025.01004","article-title":"Large-scale screening of SARS-CoV-2 variants in Tokyo, Japan: a 3-year and 9-month longitudinal survey","volume":"7","author":"Takeuchi","year":"2025","journal-title":"Glob Health Med"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129242_bb0065","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/JVI.00094-12","article-title":"Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry","volume":"86","author":"Kawase","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129242_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-28591-3","article-title":"Neutralization activity of IgG antibody in COVID-19-convalescent plasma against SARS-CoV-2 variants","volume":"13","author":"Tsuchiya","year":"2023","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129242_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofag446","article-title":"Durability and breadth of neutralizing antibodies against SARS-CoV-2 variants following XBB.1.5 vaccination in a multiply exposed cohort","volume":"13","author":"Wang","year":"2026","journal-title":"Open Forum Infect Dis"},{"issue":"47","key":"10.1016\/j.vaccine.2026.129242_bb0080","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1016\/j.vaccine.2023.10.051","article-title":"Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86","volume":"41","author":"Lasrado","year":"2023","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129242_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46490-7","article-title":"Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion","volume":"15","author":"Planas","year":"2024","journal-title":"Nat Commun"},{"issue":"Supplement_1","key":"10.1016\/j.vaccine.2026.129242_bb0090","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/cid\/ciac359","article-title":"Severe acute respiratory syndrome coronavirus 2 infection versus vaccination in pregnancy: implications for maternal and infant immunity","volume":"75","author":"Conti","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2026.129242_bb0095","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMc2209651","article-title":"Anti-spike mucosal IgA protection against SARS-CoV-2 Omicron infection","volume":"387","author":"Havervall","year":"2022","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129242_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2023.07.007","article-title":"SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals","volume":"56","author":"Sokal","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129242_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27674-x","article-title":"Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts","volume":"13","author":"Kundu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.129242_bb0110","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 breakthrough infections in vaccinated health care workers","author":"Bergwerk","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2026.129242_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiad317","article-title":"Preinfection neutralizing antibodies, Omicron BA.5 breakthrough infection, and long COVID: a propensity score-matched analysis","author":"Yamamoto","year":"2023","journal-title":"J Infect Dis"},{"issue":"68","key":"10.1016\/j.vaccine.2026.129242_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn8014","article-title":"Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants","volume":"7","author":"Bates","year":"2022","journal-title":"Sci Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129242_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-53146-7","article-title":"Validation of an MLV-based SARS-CoV-2 pseudovirus neutralization assay substantiates L455S-mediated antibody escape","volume":"16","author":"Moll","year":"2026","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129242_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/biom15010135","article-title":"Pseudotyped viruses: a useful platform for pre-clinical studies conducted in a BSL-2 laboratory setting","volume":"15","author":"Rizatdinova","year":"2025","journal-title":"Biomolecules"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:54:43Z","timestamp":1793922883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26010510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":26,"alternative-id":["S0264410X26010510"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129242","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection of Omicron XBB.1.5 vaccine, previous infection, and their induced neutralizing antibodies against symptomatic SARS-CoV-2 infection during Omicron KP.3 wave","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129242"}}